External quality assurance program oversight laboratory (EQAPOL)
Active Awarded Last action
- Contract number
- 75N93024F00001
- Awardee
-
Duke University UEI TP7EK8DZV6N5
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $7,902,910
Award facts
- Opportunity
-
- External quality assurance program oversight laboratory (EQAPOL) Pre-Solicitation · Posted Mar 8, 2023
- Contract value 23% obligated
-
- $7,902,910.00 Current, with exercised options
- $34,230,792.00 Potential, with all options
- Completion date 30% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Durham, NC 27704, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $4,012,801 | |
| Original award | $3,890,109 |
About this award
This is a $34,230,792 delivery order contract awarded to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, for an External Quality Assurance Program Oversight Laboratory (EQAPOL). The contract has a period of performance through September 29, 2031 and does not have a set-aside designation. Duke University is a prestigious private research institution that consistently secures federal contracts and grants, particularly from agencies like NIAID for advanced medical research. This contract supports a comprehensive program for pediatric drug development under the Best Pharmaceuticals for Children Act (BPCA) Pediatric Trials Network, involving establishing expert teams to develop clinical protocols, conduct pre-clinical studies, perform formulation development, and execute Phases 1-3 pediatric clinical trials. The initial task order is valued at $13.7 million.
Quick answers
Who was awarded contract 75N93024F00001?
75N93024F00001 was awarded to Duke University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 30, 2024.
How much is contract 75N93024F00001 worth?
The government has obligated $7,902,910 on 75N93024F00001. Its potential value, with all options, is $34,230,792.
Is contract 75N93024F00001 an order under another contract?
Yes. 75N93024F00001 is a delivery order under 75N93024D00003, an indefinite delivery contract.
Was contract 75N93024F00001 competed?
The extent of competition for 75N93024F00001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award